Fuan Pharmaceutical | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
38,595.40
45,867.90
65,556.20
222,126.10
284,797.60
359,932.30
Depreciation, Depletion & Amortization
35,530.10
47,594.50
86,879.60
121,331.90
149,826.40
142,483.70
Other Funds
40.90
-
6,915.60
674,409.70
1,288.80
622,180.70
Funds from Operations
67,706.90
99,640.60
162,269.90
346,857.70
429,806.90
406,489.20
Changes in Working Capital
21,054.90
127,534.40
7,306.00
22,021.00
33,597.00
122,647.90
Net Operating Cash Flow
88,761.80
27,893.80
169,575.90
368,878.70
463,404.00
283,841.20
Capital Expenditures
171,968.40
55,301.10
92,160.00
153,914.70
81,022.70
Sale of Fixed Assets & Businesses
360.50
63.60
1,784.40
1,618.90
10,719.00
Purchase/Sale of Investments
120,000.00
26,900.00
376,424.00
221,870.80
176,389.60
Net Investing Cash Flow
262,361.20
19,912.50
589,873.10
898,327.80
246,693.30
Cash Dividends Paid - Total
40,020.00
34,684.00
26,013.00
28,199.90
79,314.20
Issuance/Reduction of Debt, Net
-
187.30
67,300.00
86,853.90
54,000.00
Net Financing Cash Flow
39,979.10
34,871.30
100,228.60
559,355.90
134,602.90
Net Change in Cash
213,578.40
42,860.10
520,421.60
30,271.70
81,326.60
Free Cash Flow
83,206.60
83,194.90
77,415.90
214,964.00
382,381.30
Deferred Taxes & Investment Tax Credit
11,643.30
1,322.60
2,689.80
4,197.90
8,770.30
1,757.10
Net Assets from Acquisitions
-
-
114,437.00
525,342.60
-
Other Sources
129,476.60
102,050.00
631.10
3,155.00
-
Exchange Rate Effect
-
7.50
104.20
364.90
781.10
Other Uses
100,229.80
-
9,267.60
1,973.60
-
About Fuan Pharmaceutical
View Profile
